Revenue of $742 million, up 26% year-over-year Non-GAAP net earnings of $155 million, up 45% year-over-year, and GAAP net income of $132 million, up 44% year-over-year Operating cash flow of $153 million, up 1% year-over-year, and free cash flow of $133 million, up 8% year-over-year ANDOVER, Mass., Read more
WALTHAM, Mass., Oct. 27, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended October 2, 2021. Third Quarter 2021 Highlights Third quarter revenue increased 9% to $9.33 billion. Third quarter GAAP diluted earnings per share (EPS) was $4.79. Third... Read more
26 October 2021 Charge detection mass spectrometry adds new value to traditional mass spectrometry in detecting larger molecules such as coronaviruses. TrueMass is presenting the world’s first commercially designed charge detection mass spectrometer (CDMS) at this year’s ASMS in Philadelphia, PA. Offering the ability to enhance mass spectrometry, widely used in small molecule detection, the... Read more
ANDOVER, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, payable on Read more
Jim Schreiner to be named SVP and COO of the Atotech Division upon anticipated transaction closing Dave Henry to be named SVP, Operations and Corporate Marketing Geoff Wild, Atotech CEO, to become a member of the MKS Board of Directors ANDOVER, Mass., Oct. Read more
WALTHAM, Mass., Oct. 26, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today published its 2020 Corporate Social Responsibility (CSR) report, reflecting its commitment to society, stakeholders and environmental, social and governance (ESG) efforts. The report provides detailed insight into the company’s approach to CSR, outlines future priorities and... Read more
In a world that continues to face significant health, economic, social justice and humanitarian challenges, I couldn’t be prouder of Thermo Fisher’s role in addressing them. We are the world leader in serving science, and our responsibility encompasses both our commitment to our customers and the impact we have through our business practices and involvement... Read more
Secure, SaaS informatics platform drives streamlined workflows and accelerated decision-making for pharmaceutical and industrial customers WALTHAM, Mass. – October 25, 2021– PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its Signals Research™ Suite , a full cloud based solution, deployed on Amazon Web Services. The... Read more
The AVENIO Tumor Tissue Comprehensive Genomic Profiling (CGP) Kit is the first jointly-developed product that brings together the expertise and reach of Roche with Foundation Medicine’s pioneering leadership in genomic science. This is the first time that research scientists can conduct oncology research with Foundation Medicine’s comprehensive genomic profiling in their own laboratories to gain... Read more
Upper left: Prof. Takeo Yoshikawa, RIKEN Center for Brain Science; Upper right: Prof. Nobutaka Hirokawa, University of Tokyo; Lower, members of Dr. Hirokawa’s lab – from left to right – Dr. Momo Morikawa, Shogo Yoshihara and Dr. Yosuke Tanaka. Schizophrenia is a mental disorder in which patients often suffer hallucinations, delusions and disordered thinking that... Read more